(Q50788584)

19 March 2018

title

Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts. (English)

1 reference

19 March 2018

Alzheimer's Disease Neuroimaging Initiative

0 references

1 reference

1 reference

1 reference

series ordinal

4

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

19 March 2018

Ben Schmand

1

1 reference

19 March 2018

Piet Eikelenboom

series ordinal

2

1 reference

19 March 2018

Willem A van Gool

series ordinal

3

1 reference

19 March 2018

language of work or name

English

0 references

publication date

24 August 2011

1 reference

19 March 2018

Journal of the American Geriatrics Society

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 March 2018

volume

59

1 reference

19 March 2018

issue

9

1 reference

19 March 2018

page(s)

1705-1710

1 reference

19 March 2018

Age, neuropathology, and dementia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

CSF biomarker levels in early and late onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

The two faces of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Voxel-based morphometry–the methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Voxel-based morphometry in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Pathological verification of ischemic score in differentiation of dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03539.X

10.1111/J.1532-5415.2011.03539.X

21 January 2018

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018